🌍·1d agodiscovery
Target trial emulation using French MS registry data replicated RCT treatment effects on relapse rate and EDSS progression, but not consistently on MRI outcomes, in patients with multiple sclerosis initiating disease-modifying therapies
Publisher
V
Vera Health
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Vera Health
- Region
- Global
- Scope
- discovery
- Published
- June 26, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on news.google.com
Leave the platform to read the original full article on the publisher site.
Source: Vera Health
Scope: discovery
Related coverage
More related coverage
Federal Register/-1953m ago
Medicaid Program; Community Engagement Requirement for Certain Individuals
Federal Register/-1953m ago
Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock Absorber
The Food and Drug Administration (FDA) is classifying the medial knee implanted shock absorber into...
Federal Register/-1953m ago
Cellular, Tissue, and Gene Therapies Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Biologics License Application (BLA) 125842 From Capricor, Inc. for Deramiocel (Human Allogeneic Cardiosphere-Derived Cells)
The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of...
Federal Register/-1953m ago